Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone H3K27 trimethyltransferase activity

EZH2 NSD3

2.57e-063192GO:0140951
GeneOntologyMolecularFunctionhistone H3K27 methyltransferase activity

EZH2 NSD3

1.28e-056192GO:0046976
GeneOntologyMolecularFunctiontranscription factor binding

DCAF1 EZH2 LPIN1 BAZ2A HNRNPU PTMA

5.02e-05753196GO:0008134
GeneOntologyMolecularFunctionlncRNA binding

EZH2 HNRNPU

5.01e-0435192GO:0106222
GeneOntologyMolecularFunctionhistone H3 methyltransferase activity

EZH2 NSD3

7.92e-0444192GO:0140938
GeneOntologyMolecularFunctionmethyltransferase activity

EZH2 TRMT13 NSD3

1.02e-03213193GO:0008168
GeneOntologyMolecularFunctiontransferase activity, transferring one-carbon groups

EZH2 TRMT13 NSD3

1.18e-03224193GO:0016741
GeneOntologyMolecularFunctionmolecular adaptor activity

DCAF1 EZH2 LPIN1 BAZ2A NCBP1 HNRNPU

1.22e-031356196GO:0060090
GeneOntologyMolecularFunctioncore promoter sequence-specific DNA binding

EZH2 BAZ2A

1.24e-0355192GO:0001046
GeneOntologyMolecularFunctionhistone modifying activity

DCAF1 EZH2 NSD3

1.26e-03229193GO:0140993
GeneOntologyMolecularFunctionprotein-lysine N-methyltransferase activity

EZH2 NSD3

1.88e-0368192GO:0016279
GeneOntologyMolecularFunctionlysine N-methyltransferase activity

EZH2 NSD3

1.94e-0369192GO:0016278
GeneOntologyMolecularFunctionDNA-binding transcription factor binding

DCAF1 LPIN1 BAZ2A PTMA

1.95e-03582194GO:0140297
GeneOntologyMolecularFunctionhistone methyltransferase activity

EZH2 NSD3

2.05e-0371192GO:0042054
GeneOntologyMolecularFunctionpromoter-specific chromatin binding

EZH2 HNRNPU

2.79e-0383192GO:1990841
GeneOntologyMolecularFunctioncargo receptor activity

LRP1B MIA2

2.92e-0385192GO:0038024
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

DCAF1 EZH2 LPIN1 BAZ2A HNRNPU

3.85e-031160195GO:0030674
GeneOntologyMolecularFunctionprotein methyltransferase activity

EZH2 NSD3

4.26e-03103192GO:0008276
GeneOntologyMolecularFunctionN-methyltransferase activity

EZH2 NSD3

4.42e-03105192GO:0008170
GeneOntologyMolecularFunctionRNA polymerase II-specific DNA-binding transcription factor binding

DCAF1 LPIN1 BAZ2A

6.83e-03417193GO:0061629
GeneOntologyMolecularFunctionchromatin DNA binding

EZH2 HNRNPU

1.08e-02167192GO:0031490
GeneOntologyMolecularFunctionS-adenosylmethionine-dependent methyltransferase activity

EZH2 NSD3

1.15e-02172192GO:0008757
GeneOntologyBiologicalProcessregulation of transcription elongation by RNA polymerase II

EZH2 NCBP1 HNRNPU

8.16e-0593193GO:0034243
GeneOntologyBiologicalProcesschromatin organization

DCAF1 EZH2 BAZ2A HNRNPU NSD3 PTMA

1.10e-04896196GO:0006325
GeneOntologyBiologicalProcessregulation of DNA-templated transcription elongation

EZH2 NCBP1 HNRNPU

1.17e-04105193GO:0032784
GeneOntologyBiologicalProcessnegative regulation of transcription elongation by RNA polymerase II

EZH2 HNRNPU

1.51e-0420192GO:0034244
GeneOntologyBiologicalProcessprotein-DNA complex organization

DCAF1 EZH2 BAZ2A HNRNPU NSD3 PTMA

2.00e-04999196GO:0071824
GeneOntologyBiologicalProcessV(D)J recombination

DCAF1 EZH2

2.01e-0423192GO:0033151
GeneOntologyBiologicalProcessnegative regulation of DNA-templated transcription, elongation

EZH2 HNRNPU

2.01e-0423192GO:0032785
GeneOntologyBiologicalProcesstranscription elongation by RNA polymerase II

EZH2 NCBP1 HNRNPU

2.06e-04127193GO:0006368
GeneOntologyBiologicalProcessDNA-templated transcription elongation

EZH2 NCBP1 HNRNPU

2.98e-04144193GO:0006354
GeneOntologyBiologicalProcessmyelin assembly

GPC1 ILK

3.00e-0428192GO:0032288
GeneOntologyBiologicalProcessnegative regulation of stem cell differentiation

EZH2 HNRNPU

4.17e-0433192GO:2000737
GeneOntologyBiologicalProcessheterochromatin formation

EZH2 BAZ2A HNRNPU

4.28e-04163193GO:0031507
GeneOntologyBiologicalProcesschromatin remodeling

DCAF1 EZH2 BAZ2A HNRNPU NSD3

4.51e-04741195GO:0006338
GeneOntologyBiologicalProcessDNA methylation-dependent constitutive heterochromatin formation

EZH2 BAZ2A

7.43e-0444192GO:0006346
GeneOntologyBiologicalProcessnegative regulation of gene expression, epigenetic

EZH2 BAZ2A HNRNPU

8.10e-04203193GO:0045814
GeneOntologyBiologicalProcessmyelination

GPC1 LPIN1 ILK

8.45e-04206193GO:0042552
GeneOntologyBiologicalProcessensheathment of neurons

GPC1 LPIN1 ILK

8.82e-04209193GO:0007272
GeneOntologyBiologicalProcessaxon ensheathment

GPC1 LPIN1 ILK

8.82e-04209193GO:0008366
GeneOntologyBiologicalProcessRNA localization

NCBP1 RANBP2 HNRNPU

9.83e-04217193GO:0006403
GeneOntologyBiologicalProcessSchwann cell differentiation

GPC1 ILK

1.16e-0355192GO:0014037
GeneOntologyBiologicalProcessfacultative heterochromatin formation

EZH2 BAZ2A

1.16e-0355192GO:0140718
GeneOntologyBiologicalProcessnegative regulation of DNA-templated transcription

DCAF1 EZH2 LPIN1 BAZ2A HNRNPU NSD3

1.21e-031399196GO:0045892
GeneOntologyBiologicalProcessmethylation

EZH2 TRMT13 NSD3

1.22e-03234193GO:0032259
GeneOntologyBiologicalProcessnegative regulation of RNA biosynthetic process

DCAF1 EZH2 LPIN1 BAZ2A HNRNPU NSD3

1.28e-031413196GO:1902679
GeneOntologyCellularComponentchromatin silencing complex

EZH2 BAZ2A

7.08e-0514192GO:0005677
DomainSET

EZH2 NSD3

7.04e-0441182PF00856
DomainSET

EZH2 NSD3

8.85e-0446182SM00317
DomainSET_dom

EZH2 NSD3

1.05e-0350182IPR001214
DomainSET

EZH2 NSD3

1.05e-0350182PS50280
DomainPHD

BAZ2A NSD3

2.34e-0375182PF00628
DomainZnf_PHD-finger

BAZ2A NSD3

2.59e-0379182IPR019787
DomainEGF_CA

LRP1B THBS2

3.06e-0386182PF07645
DomainPHD

BAZ2A NSD3

3.27e-0389182SM00249
DomainZnf_PHD

BAZ2A NSD3

3.41e-0391182IPR001965
DomainZF_PHD_2

BAZ2A NSD3

3.71e-0395182PS50016
DomainZF_PHD_1

BAZ2A NSD3

3.79e-0396182PS01359
DomainEGF_CA

LRP1B THBS2

6.05e-03122182SM00179
DomainEGF-like_Ca-bd_dom

LRP1B THBS2

6.24e-03124182IPR001881
DomainEGF

LRP1B THBS2

6.44e-03126182PF00008
Domain-

BAZ2A NSD3 MARCHF6

8.61e-034491833.30.40.10
DomainZnf_FYVE_PHD

BAZ2A NSD3

8.67e-03147182IPR011011
DomainZnf_RING/FYVE/PHD

BAZ2A NSD3 MARCHF6

9.14e-03459183IPR013083
Pubmed

ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.

DCAF1 EZH2 BAZ2A RANBP2 NSD3

1.55e-0815019528242625
Pubmed

Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer.

DCAF1 EZH2

2.83e-07219237069142
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

GPC1 DCAF1 GOLIM4 NCBP1 RANBP2 HNRNPU MIA2

2.04e-06120319729180619
Pubmed

EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex.

DCAF1 EZH2

2.82e-06519223063525
Pubmed

The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase.

DCAF1 NCBP1 RANBP2 HNRNPU

5.60e-0622019434091597
Pubmed

A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.

EZH2 LPIN1 RANBP2 HNRNPU

6.91e-0623219425515538
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

EZH2 GOLIM4 ASCC2 BAZ2A RANBP2 NSD3 AFTPH

8.62e-06149719731527615
Pubmed

Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.

GPC1 DCAF1 BAZ2A NCBP1

9.43e-0625119428077445
Pubmed

Defining the membrane proteome of NK cells.

GOLIM4 RANBP2 HNRNPU ILK MARCHF6 MIA2

2.64e-05116819619946888
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

GPC1 ASCC2 NCBP1 RANBP2 HNRNPU PTMA

3.81e-05124719627684187
Pubmed

Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.

EZH2 LPIN1 HNRNPU

4.52e-0512819325332235
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

GPC1 DCAF1 BAZ2A RANBP2 HNRNPU ILK

6.01e-05135319629467282
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

GOLIM4 NCBP1 RANBP2 HNRNPU ILK MIA2

7.71e-05141519628515276
Pubmed

Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV.

DCAF1 HNRNPU

8.42e-052519215385968
Pubmed

TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.

GPC1 EZH2 GOLIM4 NCBP1 RANBP2

1.11e-0492219527609421
Pubmed

Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors.

EZH2 BAZ2A

1.14e-042919224105743
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

BAZ2A RANBP2 HNRNPU AFTPH PTMA

1.17e-0493419533916271
Pubmed

Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP.

DCAF1 HNRNPU

1.22e-043019222963397
Pubmed

BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs.

EZH2 HNRNPU

1.30e-043119223086144
Pubmed

Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase.

DCAF1 HNRNPU

1.66e-043519219287380
Pubmed

Molecular composition of IMP1 ribonucleoprotein granules.

NCBP1 HNRNPU

1.76e-043619217289661
Pubmed

Chromatin state signatures associated with tissue-specific gene expression and enhancer activity in the embryonic limb.

EZH2 HNRNPU

1.76e-043619222421546
Pubmed

Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing.

NCBP1 HNRNPU

2.18e-044019223825951
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

NCBP1 RANBP2 HNRNPU ILK

2.46e-0458219420467437
Pubmed

Armadillo repeat containing 12 promotes neuroblastoma progression through interaction with retinoblastoma binding protein 4.

EZH2 HNRNPU

2.52e-044319230026490
Pubmed

Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis.

RANBP2 HNRNPU PTMA

2.76e-0423619336339263
Pubmed

A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-κB Inhibitory Activity of the HIV-2-Encoded Vpx.

DCAF1 HNRNPU

2.76e-044519230619335
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

EZH2 BAZ2A NCBP1 NSD3

2.91e-0460819436089195
Pubmed

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.

LRP1B RANBP2 HNRNPU

3.04e-0424419330349055
Pubmed

A protein interaction landscape of breast cancer.

DCAF1 EZH2 GOLIM4 ILK

3.41e-0463419434591612
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

GPC1 GOLIM4 LRP1B MARCHF6 MIA2

3.78e-04120119535696571
Pubmed

Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells.

NCBP1 HNRNPU

4.43e-045719217932509
Pubmed

A Single Adaptable Cochaperone-Scaffold Complex Delivers Nascent Iron-Sulfur Clusters to Mammalian Respiratory Chain Complexes I-III.

DCAF1 ASCC2 RANBP2 MIA2

4.59e-0468619428380382
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

GPC1 ASCC2 NCBP1 HNRNPU NSD3

4.66e-04125719536526897
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

EZH2 BAZ2A RANBP2 HNRNPU NSD3

5.32e-04129419530804502
InteractionRAN interactions

EZH2 NCBP1 RANBP2 HNRNPU ILK PTMA

3.47e-06475196int:RAN
InteractionKPNB1 interactions

EZH2 NCBP1 RANBP2 HNRNPU ILK PTMA

7.57e-06544196int:KPNB1
InteractionTERF2IP interactions

EZH2 BAZ2A NCBP1 HNRNPU NSD3 PTMA

8.23e-06552196int:TERF2IP
InteractionCUL1 interactions

DCAF1 EZH2 LPIN1 NCBP1 RANBP2 HNRNPU ILK

9.11e-06876197int:CUL1
InteractionNUP50 interactions

EZH2 BAZ2A RANBP2 HNRNPU NSD3

1.29e-05341195int:NUP50
InteractionDHX9 interactions

EZH2 NCBP1 RANBP2 HNRNPU NSD3 MARCHF6

2.31e-05662196int:DHX9
InteractionKIF20A interactions

EZH2 LPIN1 NCBP1 RANBP2 HNRNPU NSD3 MIA2

3.00e-051052197int:KIF20A
InteractionHDAC1 interactions

DCAF1 EZH2 ASCC2 BAZ2A RANBP2 HNRNPU PTMA

4.18e-051108197int:HDAC1
InteractionSNW1 interactions

EZH2 ASCC2 NCBP1 RANBP2 HNRNPU ILK

4.56e-05747196int:SNW1
InteractionH3-4 interactions

DCAF1 EZH2 HNRNPU NSD3 PTMA

4.77e-05448195int:H3-4
InteractionMACROH2A1 interactions

DCAF1 EZH2 BAZ2A HNRNPU NSD3

5.30e-05458195int:MACROH2A1
InteractionPIN4 interactions

EZH2 ASCC2 HNRNPU

5.79e-0581193int:PIN4
InteractionNCL interactions

GPC1 DCAF1 EZH2 NCBP1 HNRNPU PTMA

6.59e-05798196int:NCL
InteractionSEPTIN6 interactions

EZH2 NSD3 PTMA

7.41e-0588193int:SEPTIN6
InteractionKPNA3 interactions

EZH2 NCBP1 RANBP2 HNRNPU

7.50e-05248194int:KPNA3
InteractionH1-1 interactions

DCAF1 EZH2 HNRNPU NSD3 PTMA

8.58e-05507195int:H1-1
InteractionYWHAE interactions

GPC1 DCAF1 EZH2 LPIN1 NCBP1 HNRNPU PTMA

9.31e-051256197int:YWHAE
InteractionKPNA2 interactions

EZH2 NCBP1 RANBP2 HNRNPU PTMA

9.58e-05519195int:KPNA2
InteractionCKB interactions

EZH2 HNRNPU ILK PTMA

1.04e-04270194int:CKB
InteractionLMNA interactions

GPC1 EZH2 BAZ2A RANBP2 HNRNPU NSD3 ILK

1.08e-041286197int:LMNA
InteractionRBX1 interactions

DCAF1 EZH2 LRP1B RANBP2 HNRNPU

1.35e-04558195int:RBX1
InteractionPCDHB1 interactions

GOLIM4 MIA2

1.43e-0419192int:PCDHB1
InteractionCUL5 interactions

DCAF1 EZH2 NCBP1 HNRNPU ILK

1.45e-04567195int:CUL5
InteractionHYDIN interactions

EZH2 HNRNPU

1.75e-0421192int:HYDIN
InteractionSUMO2 interactions

EZH2 RANBP2 HNRNPU ILK PTMA

1.76e-04591195int:SUMO2
InteractionHSPA6 interactions

DCAF1 EZH2 ILK PTMA

1.80e-04311194int:HSPA6
InteractionRNF4 interactions

GPC1 DCAF1 GOLIM4 NCBP1 RANBP2 HNRNPU MIA2

1.94e-041412197int:RNF4
InteractionHNRNPF interactions

EZH2 NCBP1 RANBP2 HNRNPU ILK

2.00e-04607195int:HNRNPF
InteractionLMNB1 interactions

EZH2 RANBP2 HNRNPU NSD3 ILK

2.04e-04610195int:LMNB1
InteractionITGB4 interactions

GPC1 HNRNPU ILK

2.10e-04125193int:ITGB4
InteractionRCHY1 interactions

DCAF1 NCBP1 RANBP2 HNRNPU

2.13e-04325194int:RCHY1
InteractionVAT1 interactions

EZH2 NCBP1 HNRNPU

2.20e-04127193int:VAT1
InteractionPTPN1 interactions

EZH2 GOLIM4 NCBP1 HNRNPU MIA2

2.29e-04625195int:PTPN1
InteractionCTNNB1 interactions

GPC1 EZH2 RANBP2 HNRNPU ILK PTMA

2.40e-041009196int:CTNNB1
InteractionATP5F1A interactions

DCAF1 EZH2 RANBP2 HNRNPU ILK

2.55e-04640195int:ATP5F1A
InteractionANP32A interactions

DCAF1 EZH2 PTMA

2.58e-04134193int:ANP32A
InteractionTRIM55 interactions

EZH2 RANBP2 HNRNPU NSD3

2.67e-04345194int:TRIM55
InteractionHSP90B1 interactions

EZH2 LPIN1 LRP1B HNRNPU PTMA

2.74e-04650195int:HSP90B1
InteractionGCN1 interactions

EZH2 NCBP1 HNRNPU ILK

2.79e-04349194int:GCN1
InteractionKPNA1 interactions

NCBP1 RANBP2 HNRNPU PTMA

2.85e-04351194int:KPNA1
InteractionPYHIN1 interactions

GPC1 DCAF1 BAZ2A NCBP1

3.07e-04358194int:PYHIN1
InteractionSRP14 interactions

GPC1 DCAF1 EZH2 PTMA

3.34e-04366194int:SRP14
InteractionMAP10 interactions

DCAF1 HNRNPU

3.37e-0429192int:MAP10
InteractionBOD1L1 interactions

EZH2 NCBP1 NSD3

3.52e-04149193int:BOD1L1
InteractionRPL13 interactions

GPC1 DCAF1 EZH2 HNRNPU ILK

3.86e-04700195int:RPL13
InteractionRB1CC1 interactions

EZH2 NCBP1 HNRNPU NSD3

4.13e-04387194int:RB1CC1
InteractionSYNCRIP interactions

GPC1 EZH2 NCBP1 HNRNPU PTMA

4.42e-04721195int:SYNCRIP
InteractionHSPA9 interactions

GPC1 EZH2 NCBP1 HNRNPU PTMA

4.60e-04727195int:HSPA9
InteractionCUL4B interactions

DCAF1 EZH2 GOLIM4 LRP1B NCBP1

4.63e-04728195int:CUL4B
InteractionHDAC4 interactions

GPC1 EZH2 RANBP2 HNRNPU PTMA

5.11e-04744195int:HDAC4
InteractionH3-3A interactions

DCAF1 EZH2 BAZ2A NCBP1 NSD3

5.27e-04749195int:H3-3A
InteractionSMARCA5 interactions

EZH2 BAZ2A RANBP2 HNRNPU

5.37e-04415194int:SMARCA5
InteractionALYREF interactions

EZH2 NCBP1 HNRNPU ILK

5.42e-04416194int:ALYREF
InteractionMYH9 interactions

DCAF1 EZH2 ASCC2 HNRNPU PTMA

5.43e-04754195int:MYH9
InteractionDYRK2 interactions

DCAF1 NCBP1 HNRNPU

5.44e-04173193int:DYRK2
InteractionDDX17 interactions

EZH2 RANBP2 HNRNPU ILK

5.93e-04426194int:DDX17
InteractionSRP9 interactions

GPC1 EZH2 HNRNPU PTMA

5.98e-04427194int:SRP9
InteractionGPC1 interactions

GPC1 EZH2 HNRNPU

6.01e-04179193int:GPC1
InteractionRORA interactions

DCAF1 EZH2

6.11e-0439192int:RORA
InteractionAGO1 interactions

NCBP1 TRMT13 HNRNPU

6.41e-04183193int:AGO1
InteractionNSFL1C interactions

GPC1 EZH2 PTMA

7.37e-04192193int:NSFL1C
InteractionPABPN1 interactions

EZH2 NCBP1 HNRNPU

7.37e-04192193int:PABPN1
InteractionSTMN1 interactions

GPC1 EZH2 PTMA

7.71e-04195193int:STMN1
InteractionC2CD4B interactions

DCAF1 LRP1B

7.78e-0444192int:C2CD4B
InteractionRPL27A interactions

GPC1 DCAF1 EZH2 HNRNPU

7.84e-04459194int:RPL27A
InteractionRCC1 interactions

EZH2 RANBP2 PTMA

8.42e-04201193int:RCC1
InteractionPRMT5 interactions

EZH2 NCBP1 RANBP2 HNRNPU

8.64e-04471194int:PRMT5
InteractionFBXW11 interactions

EZH2 LPIN1 RANBP2 HNRNPU

8.78e-04473194int:FBXW11
InteractionRGPD3 interactions

RANBP2 MIA2

8.88e-0447192int:RGPD3
InteractionABCF2 interactions

EZH2 HNRNPU ILK

9.42e-04209193int:ABCF2
InteractionRANBP1 interactions

EZH2 RANBP2 PTMA

9.69e-04211193int:RANBP1
InteractionH3C3 interactions

EZH2 BAZ2A NCBP1 NSD3

1.04e-03495194int:H3C3
InteractionRPS6KL1 interactions

GOLIM4 RANBP2

1.04e-0351192int:RPS6KL1
InteractionRPS6 interactions

DCAF1 EZH2 ASCC2 HNRNPU NSD3

1.06e-03874195int:RPS6
InteractionDHX15 interactions

EZH2 RANBP2 HNRNPU ILK

1.10e-03502194int:DHX15
InteractionKPNA4 interactions

EZH2 NCBP1 RANBP2

1.17e-03225193int:KPNA4
InteractionILF3 interactions

GPC1 EZH2 NCBP1 HNRNPU ILK

1.19e-03896195int:ILF3
InteractionRPS20 interactions

GPC1 EZH2 ASCC2 NCBP1

1.19e-03513194int:RPS20
InteractionRPS9 interactions

DCAF1 EZH2 NCBP1 HNRNPU

1.20e-03515194int:RPS9
InteractionFBXO34 interactions

NCBP1 HNRNPU

1.21e-0355192int:FBXO34
InteractionH3C1 interactions

DCAF1 EZH2 BAZ2A HNRNPU NSD3

1.22e-03901195int:H3C1
InteractionARMC12 interactions

EZH2 HNRNPU

1.26e-0356192int:ARMC12
InteractionS100A6 interactions

GPC1 EZH2 RANBP2

1.29e-03233193int:S100A6
CytobandEnsembl 112 genes in cytogenetic band chr2q37

GPC1 PTMA

3.90e-03226192chr2q37
GeneFamilyZinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family

EZH2 NSD3

1.87e-0434112487
GeneFamilyPHD finger proteins

BAZ2A NSD3

1.31e-039011288
CoexpressionGOLDRATH_IMMUNE_MEMORY

GPC1 GOLIM4 LPIN1

1.44e-0566193M10845
CoexpressionGOLDRATH_IMMUNE_MEMORY

GPC1 GOLIM4 LPIN1

1.64e-0569193MM621
CoexpressionSCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN

GPC1 GOLIM4 HNRNPU AFTPH MIA2

1.66e-05467195M1347
CoexpressionSCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN

GPC1 GOLIM4 HNRNPU AFTPH MIA2

1.97e-05484195MM999
CoexpressionGRUETZMANN_PANCREATIC_CANCER_UP

GPC1 GOLIM4 THBS2 HNRNPU

1.14e-04359194M15193
CoexpressionGAZIN_EPIGENETIC_SILENCING_BY_KRAS

EZH2 BAZ2A

1.48e-0425192M1770
CoexpressionWAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK

BAZ2A NCBP1 AFTPH

1.57e-04147193MM1316
CoexpressionWAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK

BAZ2A NCBP1 AFTPH

1.60e-04148193M2420
CoexpressionGAZIN_EPIGENETIC_SILENCING_BY_KRAS

EZH2 BAZ2A

1.73e-0427192MM744
CoexpressionGSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP

GOLIM4 ILK MIA2

2.24e-04166193M6811
CoexpressionGSE21033_3H_VS_24H_POLYIC_STIM_DC_UP

BAZ2A NSD3 AFTPH

2.24e-04166193M7722
CoexpressionZHANG_BREAST_CANCER_PROGENITORS_UP

EZH2 NCBP1 HNRNPU MARCHF6

2.36e-04434194M15150
CoexpressionZHANG_BREAST_CANCER_PROGENITORS_UP

EZH2 NCBP1 HNRNPU MARCHF6

2.66e-04448194MM1044
CoexpressionGSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN

EZH2 HNRNPU PTMA

2.71e-04177193M394
CoexpressionCUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE

GPC1 GOLIM4 MARCHF6

2.80e-04179193M39308
CoexpressionGSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP

DCAF1 GOLIM4 MIA2

3.23e-04188193M8452
CoexpressionVERRECCHIA_DELAYED_RESPONSE_TO_TGFB1

THBS2 ILK

3.27e-0437192M16643
CoexpressionDODD_NASOPHARYNGEAL_CARCINOMA_UP

EZH2 NCBP1 RANBP2 THBS2 HNRNPU NSD3

3.51e-041407196M14427
CoexpressionBROWNE_HCMV_INFECTION_48HR_DN

GOLIM4 LPIN1 THBS2 HNRNPU

3.52e-04482194M12144
CoexpressionGSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP

GOLIM4 RANBP2 MIA2

3.54e-04194193M6493
CoexpressionPYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP

EZH2 HNRNPU NSD3

3.60e-04195193M13736
CoexpressionGSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN

LPIN1 MARCHF6 AFTPH

3.71e-04197193M9879
CoexpressionGSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN

DCAF1 EZH2 AFTPH

3.71e-04197193M5342
CoexpressionGSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN

NCBP1 RANBP2 AFTPH

3.76e-04198193M6104
CoexpressionGSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN

EZH2 LPIN1 NCBP1

3.82e-04199193M8542
CoexpressionGSE2585_THYMIC_DC_VS_MTEC_UP

DCAF1 LRP1B MIA2

3.82e-04199193M6289
CoexpressionGSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN

ASCC2 LPIN1 HNRNPU

3.82e-04199193M3919
CoexpressionGSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN

DCAF1 GOLIM4 RANBP2

3.82e-04199193M6932
CoexpressionGSE2585_THYMIC_DC_VS_MTEC_DN

DCAF1 THBS2 HNRNPU

3.88e-04200193M6283
CoexpressionGSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN

EZH2 LPIN1 MARCHF6

3.88e-04200193M3188
CoexpressionGSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN

GPC1 DCAF1 NCBP1

3.88e-04200193M4027
CoexpressionGSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP

NSD3 MARCHF6 MIA2

3.88e-04200193M6092
CoexpressionGOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN

GPC1 GOLIM4 LPIN1

3.88e-04200193M3039
CoexpressionCHICAS_RB1_TARGETS_SENESCENT

EZH2 THBS2 NSD3 PTMA

6.40e-04565194M2125
CoexpressionHEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS

GOLIM4 BAZ2A

7.23e-0455192MM397
CoexpressionYAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2

THBS2 HNRNPU

8.03e-0458192M2021
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5

EZH2 GOLIM4 NCBP1 RANBP2 HNRNPU AFTPH

6.18e-05831196Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlasFacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3

EZH2 THBS2 HNRNPU AFTPH

8.65e-05271194Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#1

GPC1 DCAF1 TRMT13 ILK PTMA

1.85e-04629195Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K1
ToppCell367C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

GPC1 GOLIM4 ILK

4.74e-0516819380233a13135fd159f5764336a1fe67fba237776b
ToppCellBrain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.

EZH2 BAZ2A NSD3

6.31e-05185193857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

EZH2 GOLIM4 PTMA

6.42e-0518619338f9f7d3b782978fd23b2a7fe565266285d39e44
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

EZH2 GOLIM4 PTMA

6.62e-05188193e35104ca327c2d9eb6ffed658051f62f855a0a0e
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

EZH2 GOLIM4 PTMA

6.94e-051911935c0c44612b4cdbf89c0f1f219416374a7541f610
ToppCelldroplet-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EZH2 HNRNPU PTMA

7.05e-05192193d9e61b2722aa81e4f6e11865a04f2f1e75b794ab
ToppCell3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue

EZH2 GOLIM4 LPIN1

7.38e-051951931470f562ebcfe7da367964ecfd6c7f43bcdb4a73
ToppCelldroplet-Thymus-nan-21m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EZH2 HNRNPU PTMA

7.38e-051951932416efe0b10ef28d0107808d1347bc34f87f92b7
ToppCelldroplet-Tongue-nan-3m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GOLIM4 ILK PTMA

7.49e-0519619327364b577d77aefaa147abb346c46fce61e28ec3
ToppCelldroplet-Thymus-nan-21m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EZH2 HNRNPU PTMA

7.49e-05196193313d66313d7c93d9ae4c8b790262ba7a85b34fe4
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

EZH2 HNRNPU PTMA

7.61e-0519719304aaf35ef4db6325b2b2b92e93272f1973764b78
ToppCellP03-Mesenchymal-myocytic_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

THBS2 ILK PTMA

7.61e-05197193079db904a08743b3c555cb7b3f5fb5c978dde25a
ToppCellTCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9

DCAF1 BAZ2A RANBP2

7.72e-0519819362cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCellTCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9

DCAF1 BAZ2A RANBP2

7.72e-05198193af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

GOLIM4 THBS2 ILK

7.72e-05198193a699b365d3b6149f13f02b2e2ae9b6fdce761848
ToppCellTCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9

DCAF1 BAZ2A RANBP2

7.72e-05198193ad39cce004867f083f8da1954e0cf5a263815184
ToppCell3'-Adult-Appendix-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GOLIM4 HNRNPU PTMA

7.84e-05199193d1a3eaef9e84d0572776e8468099d669b8a98ef7
ToppCell3'-Adult-Appendix-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GOLIM4 HNRNPU PTMA

7.84e-051991937ff034b384f8fa4e027025aa5bf8cb856d793b18
ToppCell3'-Adult-Appendix-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GOLIM4 HNRNPU PTMA

7.84e-0519919377bdd3df106c05acc173555ce13243d93c50e94d
ToppCellwk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

LRP1B THBS2 ILK

7.84e-05199193a207b4891881149d4c50721310690fd794157723
ToppCelllymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass

EZH2 BAZ2A RANBP2

7.84e-05199193945fbf5845403a8b22d04963f50ad69c414b6153
ToppCell3'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GOLIM4 HNRNPU PTMA

7.84e-0519919332ff62019535ea30059b63a2686c565baa54bfee
ToppCell343B-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

DCAF1 THBS2

1.89e-0315319232cf4ca828d228f23366480305592f9813fed7ff
ToppCell343B-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

DCAF1 THBS2

1.89e-03153192d5f5399ebbbff508c96ce7f01272716b61597ab5
ToppCellIIH-Treg|IIH / Condition, Cell_class and T cell subcluster

EZH2 NSD3

1.89e-0315319217704e18833812fcf2a2727b1e3f8a9984ba5b59
ToppCellIIH-Treg-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster

EZH2 NSD3

1.92e-03154192d2211a892654b92decb208969040920f7ae8ba1e
ToppCellfacs-BAT-Fat-24m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 ASCC2

1.94e-03155192550e7e7e52829244ead829e5be010bfdc71e2ba5
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9

LPIN1 LRP1B

2.09e-03161192347edb0de10850b7d16c40945751033289289c9b
ToppCellAdult-Mesenchymal-myofibroblast_cell-D175|Adult / Lineage, Cell type, age group and donor

GPC1 THBS2

2.09e-03161192048b7dc00746987a24bf870d4d278c4183eb04a2
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

EZH2 THBS2

2.09e-03161192a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

EZH2 THBS2

2.09e-0316119208920a716f6ec62538e361211455a30ad726d7be
ToppCellfacs-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 LPIN1

2.17e-03164192a187bd5beca017ef657ef07c006e7f94ea3b911b
ToppCellfacs-BAT-Fat-18m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 LPIN1

2.17e-03164192ab9c17f86b98e1a4d5db1bd3086edab1320ebda8
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASCC2 LRP1B

2.19e-031651920edd56e8d14eaeced9882dd9206ea93e8f402e8d
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASCC2 LRP1B

2.19e-03165192fa3aadfff6fb1e7f142db333c60c2cba02b17e6c
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9

DCAF1 HNRNPU

2.22e-0316619232d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCelldroplet-Spleen-nan-21m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 LPIN1

2.25e-0316719292ddabbe55315856d8ea6f8db1560b6d97636bac
ToppCellfacs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 LPIN1

2.27e-0316819274dc46738f1d0a448df6c9b8288b515d92697792
ToppCellPND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EZH2 NCBP1

2.30e-0316919220fbf78382fb0ba9a63ab1aa0abc615476994ac5
ToppCellfacs-SCAT-Fat-18m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LPIN1 NSD3

2.30e-03169192700a3a36c379872585204caa6a6cc269b036ae22
ToppCellASK454-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

MIA2 PTMA

2.33e-0317019284705434234bf2fbb5256bd5a1f6ab54c01c5a51
ToppCell10x5'-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue

GPC1 EZH2

2.35e-03171192976361f67dd725870e0513ae7a92f2dcaee17148
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

RANBP2 HNRNPU

2.35e-031711922e9a20f8980b78325c52065a9c14ab3656267c05
ToppCellLymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4)

EZH2 PTMA

2.38e-03172192f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c
ToppCellASK454-Immune-NK_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

MIA2 PTMA

2.38e-03172192c9e738c3540ee09b08805b1cdb66b4a0d9d40d33
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_1|356C / Donor, Lineage, Cell class and subclass (all cells)

TRMT13 NSD3

2.41e-03173192e3cb7c8c09f937da6b8d673e9adfec5d94a15548
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

GOLIM4 LRP1B

2.41e-03173192a55f310c533432e9e26e400026a5b47245152976
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GOLIM4 LRP1B

2.41e-031731929c7386bf0a899882c733f0b4921a96afde032a7d
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

GPC1 LPIN1

2.44e-03174192583955b4db442ba0583e2312af242f050547f9d6
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EZH2 PTMA

2.44e-03174192c2fc78dd6c440737ded59676961e4c7b923084ce
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EZH2 PTMA

2.44e-03174192021ebc6ec022b992d7b25333ba0b7416371e041b
ToppCellfacs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 LRP1B

2.46e-03175192d8e385320f554d974538b7cdc4f8e4767f1455f2
ToppCellfacs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 LRP1B

2.46e-03175192cf15465855602ba135752c18755e3e058dbd42ec
ToppCellfacs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

THBS2 PTMA

2.46e-0317519221542be95059983d2c8bdf01ec711fdbf1ec1f62
ToppCellfacs-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 LPIN1

2.49e-03176192a23d484aff5ad094333b2feae9106ca219514711
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP1B PTMA

2.49e-03176192c6484334187f64cd00cd35e77d8ae436556b4260
ToppCell343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells)

LRP1B THBS2

2.49e-031761922e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GOLIM4 RANBP2

2.49e-03176192749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells)

LRP1B THBS2

2.49e-03176192f33ab41d121b59d871ad7d48ca021524a027d2ef
ToppCelldroplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EZH2 ASCC2

2.49e-031761921510cdfcfb46ce1196a1220c07fb5f3986c81b78
ToppCell(1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class

GPC1 PTMA

2.52e-03177192d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1
ToppCell(01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint

EZH2 PTMA

2.52e-0317719205c57578142a6662f18b294d5cc11e6efd6b0f8e
ToppCell10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

GPC1 THBS2

2.52e-03177192915b848d789051a1c3bc6f6dc86955bb752276ab
ToppCellfacs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HNRNPU NSD3

2.55e-03178192b505e2550860e777535ee95f29c936242fd607f1
ToppCellCOVID-19_Convalescent-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class

DCAF1 TRMT13

2.57e-031791929d51318ac198a8801bd5c7031ebf2b0c74ffeeb6
ToppCellCOVID-19_Convalescent-Classical_Monocyte-cMono_4|COVID-19_Convalescent / Disease condition and Cell class

DCAF1 TRMT13

2.57e-03179192366e4a31db9e80fd1770ac9f1ae148fefeb9f7df
ToppCell356C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

GOLIM4 LPIN1

2.60e-03180192cedbe692c5257fb6f9a552e2f197163626ac17d9
ToppCellRA-11._Adipocyte|RA / Chamber and Cluster_Paper

LPIN1 LRP1B

2.60e-03180192d48a3d27357f7d184132a6805950f93080146b59
ToppCell368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DCAF1 GOLIM4

2.60e-03180192eb5a57604c7f2ad256c300085dbf5069d0ae1ad0
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

LRP1B MARCHF6

2.60e-03180192cf7d8bf9eee2dfab2c8a6780e296b05ad42041bf
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EZH2 PTMA

2.60e-03180192e76ccbaba18ff27abbd71a41fd3574a5ac5c8fb4
ToppCell368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DCAF1 GOLIM4

2.60e-03180192ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 GOLIM4

2.63e-03181192566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9

LPIN1 MIA2

2.63e-031811928fcc9e77fee7c248df26b6c59b10e672242e2084
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 GOLIM4

2.63e-03181192db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCellLymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4)

EZH2 PTMA

2.63e-03181192b6b41cd5d43543fe7a093033dae52a789199db0e
ToppCellB_cell_maturation-immature_B_cell|World / Lineage and Cell class

BAZ2A PTMA

2.66e-031821922c7c51ebc4125d8a33454ffee0b143579ce5e451
ToppCelldroplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 EZH2

2.66e-031821920370b395ceb9d4d66f80cf60dd8c28ac60af5c7b
ToppCellfacs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 GOLIM4

2.66e-03182192c075756cd4bb484ede1be2bcdb9eac60eab0573a
ToppCellfacs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 GOLIM4

2.66e-031821929025178ede571e3808d4657ad4892152f336c9b4
ToppCellLA-11._Adipocyte|World / Chamber and Cluster_Paper

LPIN1 LRP1B

2.69e-03183192b177be283e1553fb1f69a346f1ba79ad00297fa2
ToppCellImmune_cells-large_pre-B.|World / Lineage and Cell class

EZH2 PTMA

2.69e-0318319281b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e
ToppCellLA-11._Adipocyte|LA / Chamber and Cluster_Paper

LPIN1 LRP1B

2.69e-031831923f9011976782fa8aa95cdd6f00f07a91094d411b
ToppCell368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

GPC1 NCBP1

2.69e-03183192fef51dcf180e6d4e136362c7e140ec5ef372e6d0
ToppCell368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

GPC1 NCBP1

2.69e-03183192310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue

GPC1 EZH2

2.69e-03183192a48a6313f2f144586951cece97ec31f6d72361df
ToppCellHippocampus-Macroglia|Hippocampus / BrainAtlas - Mouse McCarroll V32

EZH2 PTMA

2.72e-03184192a1d039ddf1e2a87b870f3ce6d139be56090349df
ToppCellnormal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass

GPC1 THBS2

2.72e-031841920b336489c10e8c3c957795dd845454f03404382b
ToppCellTCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9

GPC1 GOLIM4

2.72e-03184192ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCellControl-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations)

EZH2 PTMA

2.75e-031851929766216b41ee62bbac4caa25cb98ec5627a24075
ToppCellnucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

EZH2 NSD3

2.75e-03185192a86a3a1a187a4d8d7762bc6d3dcb22c982178d22
ToppCellfacs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 HNRNPU

2.78e-031861929a7932d0a208f3997216bd21a72913cc82b59fc9
ToppCelldroplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GPC1 THBS2

2.78e-031861924e983de6d2515082f9e555f4f949cec84281c140
ToppCell10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

LPIN1 LRP1B

2.78e-03186192b099cb0902e9afb11218d70407d3cab212343c6d
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LRP1B THBS2

2.78e-031861927582b5154d8e5a4434817b5ab77a10b789ea2288
ToppCell3'|World / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GOLIM4 PTMA

2.78e-03186192e265aac37f33947ff6c83f23f8a2c63bbccd60af
ToppCelldroplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RANBP2 NSD3

2.80e-03187192663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

RANBP2 HNRNPU

2.80e-03187192e61c1755531469dd3850c9740474b5ad4e0499c1
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

EZH2 GOLIM4

2.80e-03187192d17352f769c3c66601b65d060626eecff41b0482
ToppCelldroplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 GOLIM4

2.80e-0318719214c239af77116d28d511dea754b6150d20488080
DrugMephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A

LPIN1 BAZ2A NCBP1 HNRNPU NSD3

5.23e-072001953425_UP
DrugClemizole hydrochloride [1163-36-6]; Down 200; 11uM; PC3; HT_HG-U133A

GPC1 DCAF1 BAZ2A MIA2

1.76e-051931943672_DN
DrugSC 19220; Up 200; 10uM; PC3; HT_HG-U133A

BAZ2A HNRNPU NSD3 MIA2

1.79e-051941947065_UP
DrugFelodipine [72509-76-3]; Down 200; 10.4uM; PC3; HT_HG-U133A

LPIN1 BAZ2A NCBP1 NSD3

1.79e-051941946695_DN
Drugazathioprine, USP; Up 200; 100uM; MCF7; HG-U133A

GPC1 BAZ2A NSD3 ILK

1.83e-05195194338_UP
DrugEthisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A

NCBP1 HNRNPU MARCHF6 MIA2

1.83e-051951943864_DN
Drugestradiol, USP; Up 200; 0.01uM; ssMCF7; HG-U133A

GPC1 DCAF1 BAZ2A HNRNPU

1.87e-05196194414_UP
DrugTiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A

GPC1 BAZ2A HNRNPU MIA2

1.90e-051971947311_UP
DrugTetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A

BAZ2A HNRNPU NSD3 MIA2

1.90e-051971943338_DN
DrugBetonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A

LPIN1 NCBP1 HNRNPU NSD3

1.90e-051971946063_DN
DrugChlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A

LPIN1 TRMT13 NSD3 MIA2

1.90e-051971941541_DN
DrugKhellin [82-02-0]; Down 200; 15.4uM; MCF7; HT_HG-U133A

GPC1 LPIN1 NSD3 MIA2

1.90e-051971941504_DN
DrugFlunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A

BAZ2A NSD3 MARCHF6 MIA2

1.94e-051981946023_DN
DrugLomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; HL60; HT_HG-U133A

DCAF1 BAZ2A NSD3 MIA2

1.94e-051981942348_DN
DrugHaloperidol [52-86-8]; Up 200; 10.6uM; PC3; HG-U133A

GPC1 ASCC2 LPIN1 BAZ2A

1.94e-051981941955_UP
DrugLevopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A

DCAF1 LPIN1 BAZ2A HNRNPU

1.98e-051991943543_DN
DrugLomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A

LPIN1 BAZ2A NSD3 MIA2

1.98e-051991942310_DN
DrugAC1L71LN

EZH2 RANBP2 PTMA

1.57e-04128193CID000327966
DrugUV-C

RANBP2 HNRNPU PTMA

3.21e-04163193CID005289542
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA

LPIN1 BAZ2A NSD3

3.95e-041751931006_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA

LPIN1 BAZ2A MARCHF6

4.15e-04178193916_UP
DrugAdiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A

GOLIM4 BAZ2A MARCHF6

4.50e-041831931709_DN
DrugNimodipine [66085-59-4]; Up 200; 9.6uM; HL60; HT_HG-U133A

GPC1 DCAF1 HNRNPU

4.65e-041851933103_UP
Drugprochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A

LPIN1 BAZ2A NSD3

4.80e-041871936975_UP
DrugLovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A

LPIN1 BAZ2A MIA2

4.87e-041881932854_UP
DrugAntimycin A [1397-94-0]; Down 200; 7.2uM; HL60; HG-U133A

BAZ2A NCBP1 HNRNPU

4.87e-041881931414_DN
DrugPrimaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A

GOLIM4 BAZ2A MARCHF6

4.87e-041881934845_DN
DrugLoperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HT_HG-U133A

LPIN1 NSD3 MARCHF6

4.95e-041891934672_UP
Drugradicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

LPIN1 BAZ2A NSD3

4.95e-04189193836_UP
DrugIvermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A

GPC1 MARCHF6 MIA2

4.95e-041891937206_UP
DrugF0447-0125; Up 200; 10uM; PC3; HT_HG-U133A

LPIN1 NSD3 MIA2

5.02e-041901936429_UP
DrugAC1MQZ6I

EZH2 LPIN1 ILK

5.02e-04190193CID003509873
DrugFenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A

BAZ2A NSD3 MARCHF6

5.10e-041911934279_DN
Drug17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

LPIN1 NCBP1 MARCHF6

5.10e-04191193993_UP
DrugDrofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A

DCAF1 BAZ2A NSD3

5.10e-041911936776_UP
DrugAlbendazole [54965-21-8]; Down 200; 15uM; MCF7; HT_HG-U133A

BAZ2A HNRNPU NSD3

5.18e-041921933164_DN
DrugDipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A

GOLIM4 LPIN1 TRMT13

5.18e-041921931517_DN
DrugSulfamethoxazole [723-46-6]; Down 200; 15.8uM; HL60; HT_HG-U133A

BAZ2A HNRNPU NSD3

5.18e-041921932335_DN
DrugBetamethasone [378-44-9]; Up 200; 10.2uM; PC3; HT_HG-U133A

BAZ2A NCBP1 MARCHF6

5.18e-041921936728_UP
DrugChlorhexidine [55-56-1]; Up 200; 8uM; MCF7; HT_HG-U133A

DCAF1 BAZ2A MIA2

5.18e-041921931525_UP
DrugEthynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A

DCAF1 LPIN1 BAZ2A

5.26e-041931936678_UP
DrugNaphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HT_HG-U133A

LPIN1 HNRNPU NSD3

5.26e-041931936604_DN
DrugCarisoprodol [78-44-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A

BAZ2A NSD3 MARCHF6

5.26e-041931933251_UP
Drugprochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HG-U133A

LPIN1 BAZ2A ILK

5.26e-04193193455_UP
DrugZidovudine, AZT [30516-87-1]; Up 200; 15uM; PC3; HT_HG-U133A

NCBP1 MARCHF6 MIA2

5.26e-041931936733_UP
DrugClorgyline hydrochloride [17780-75-5]; Up 200; 13uM; MCF7; HT_HG-U133A

GPC1 DCAF1 NSD3

5.26e-041931935005_UP
DrugButoconazole nitrate [32872-77-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A

DCAF1 NSD3 MARCHF6

5.34e-041941933288_UP
DrugQuercetine dihydrate [6151-25-3]; Down 200; 11.8uM; PC3; HT_HG-U133A

LPIN1 NCBP1 MIA2

5.34e-041941934264_DN
DrugCP-690334-01 [459212-38-5]; Up 200; 10uM; MCF7; HT_HG-U133A

LPIN1 BAZ2A NSD3

5.34e-041941933906_UP
DrugCP-645525-01 [287190-82-3]; Up 200; 10uM; PC3; HT_HG-U133A

LPIN1 HNRNPU MIA2

5.34e-041941937527_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A

BAZ2A HNRNPU NSD3

5.34e-041941932474_DN
DrugTolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; PC3; HT_HG-U133A

LPIN1 NCBP1 MIA2

5.34e-041941934262_DN
DrugChlorthalidone [77-36-1]; Down 200; 11.8uM; HL60; HG-U133A

BAZ2A RANBP2 TRMT13

5.34e-041941931581_DN
DrugDapsone [80-08-0]; Up 200; 16.2uM; HL60; HT_HG-U133A

LPIN1 BAZ2A HNRNPU

5.34e-041941931868_UP
DrugCarteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A

LPIN1 HNRNPU MARCHF6

5.34e-041941934176_DN
DrugKhellin [82-02-0]; Up 200; 15.4uM; MCF7; HT_HG-U133A

BAZ2A HNRNPU MARCHF6

5.34e-041941934987_UP
DrugGriseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A

LPIN1 BAZ2A HNRNPU

5.34e-041941932293_DN
DrugHexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A

GPC1 DCAF1 NSD3

5.42e-041951936244_UP
DrugST021200; Down 200; 10uM; PC3; HT_HG-U133A

GPC1 HNRNPU MIA2

5.42e-041951937493_DN
DrugAntazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A

NCBP1 HNRNPU MIA2

5.42e-041951933173_DN
DrugIndapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A

BAZ2A HNRNPU NSD3

5.42e-041951933778_DN
DrugFamprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A

LPIN1 HNRNPU MARCHF6

5.42e-041951933834_DN
DrugCytisine (-) [485-35-8]; Down 200; 21uM; PC3; HT_HG-U133A

NCBP1 HNRNPU MIA2

5.42e-041951935739_DN
DrugOxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A

GPC1 LPIN1 BAZ2A

5.42e-041951934969_UP
DrugClomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; MCF7; HT_HG-U133A

LPIN1 BAZ2A MIA2

5.42e-041951932624_UP
DrugLactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A

BAZ2A MARCHF6 MIA2

5.42e-041951933246_UP
DrugMetoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A

GOLIM4 HNRNPU NSD3

5.42e-041951934508_DN
Drugtrichostatin A; Up 200; 0.1uM; ssMCF7; HG-U133A

DCAF1 BAZ2A NSD3

5.50e-04196193413_UP
DrugDehydrocholic acid [81-23-2]; Down 200; 9.6uM; HL60; HG-U133A

ASCC2 HNRNPU ILK

5.50e-041961932023_DN
DrugCinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A

BAZ2A RANBP2 TRMT13

5.50e-041961931558_DN
DrugAmethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A

DCAF1 NSD3 MIA2

5.50e-041961935000_UP
DrugEthambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A

GPC1 DCAF1 HNRNPU

5.50e-041961934120_DN
DrugEucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A

NCBP1 NSD3 MIA2

5.50e-041961933416_UP
DrugAminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A

GPC1 BAZ2A NSD3

5.50e-041961933726_DN
DrugLY 294002; Down 200; 10uM; HL60; HT_HG-U133A

GPC1 LPIN1 HNRNPU

5.50e-041961932687_DN
DrugHydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; MCF7; HT_HG-U133A

GOLIM4 HNRNPU NSD3

5.50e-041961931524_DN
Drug1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A

EZH2 LPIN1 BAZ2A

5.50e-041961932_DN
DrugCefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; MCF7; HT_HG-U133A

LPIN1 BAZ2A HNRNPU

5.50e-041961934718_UP
DrugEsculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A

BAZ2A NSD3 MIA2

5.50e-041961935411_DN
DrugSisomicin sulfate [53179-09-2]; Down 200; 2.8uM; HL60; HT_HG-U133A

BAZ2A HNRNPU MARCHF6

5.50e-041961932493_DN
DrugGlibenclamide [10238-21-8]; Up 200; 8uM; PC3; HT_HG-U133A

LPIN1 BAZ2A HNRNPU

5.50e-041961935849_UP
DrugDiphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A

GOLIM4 NSD3 MIA2

5.50e-041961931494_DN
DrugSulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A

HNRNPU NSD3 MARCHF6

5.50e-041961935257_DN
Drugpentamidine isethionate salt; Down 200; 100uM; MCF7; HG-U133A

ASCC2 BAZ2A HNRNPU

5.58e-04197193639_DN
DrugDroperidol [548-73-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A

DCAF1 BAZ2A HNRNPU

5.58e-041971932645_UP
DrugTetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; PC3; HT_HG-U133A

DCAF1 LPIN1 MARCHF6

5.58e-041971934078_UP
DrugFuraltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A

LPIN1 NSD3 MARCHF6

5.58e-041971933838_DN
DrugTrichlorfon [52-68-6]; Up 200; 15.6uM; MCF7; HT_HG-U133A

DCAF1 BAZ2A NSD3

5.58e-041971931675_UP
Drug0198306-0000 [212631-61-3]; Down 200; 10uM; MCF7; HT_HG-U133A

GOLIM4 RANBP2 NSD3

5.58e-041971937064_DN
Druggenistein; Down 200; 10uM; PC3; HG-U133A

GOLIM4 ASCC2 LPIN1

5.58e-04197193703_DN
DrugHarmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; HL60; HG-U133A

BAZ2A HNRNPU NSD3

5.58e-041971931750_UP
DrugDubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A

GPC1 DCAF1 HNRNPU

5.58e-041971936250_UP
DrugHeliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A

LPIN1 NCBP1 NSD3

5.58e-041971934277_DN
DrugChlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A

DCAF1 BAZ2A HNRNPU

5.58e-041971934142_DN
DrugMyosmine [532-12-7]; Down 200; 27.4uM; MCF7; HT_HG-U133A

LPIN1 BAZ2A HNRNPU

5.58e-041971936055_DN
DrugMoxonidine [75438-57-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A

GPC1 NSD3 MIA2

5.58e-041971937343_UP
DrugDexamethasone acetate [1177-87-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A

GPC1 DCAF1 LPIN1

5.58e-041971936271_UP
DrugCinchonine [118-10-5]; Up 200; 13.6uM; PC3; HT_HG-U133A

BAZ2A NCBP1 MIA2

5.58e-041971933988_UP
DrugProxyphylline [603-00-9]; Down 200; 16.8uM; PC3; HT_HG-U133A

GPC1 LPIN1 MIA2

5.58e-041971937290_DN
DrugSulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A

LPIN1 NCBP1 NSD3

5.58e-041971931463_DN
Diseasehepatocellular carcinoma (is_marker_for)

GPC1 EZH2 LRP1B

7.66e-04301183DOID:684 (is_marker_for)
Diseasestomach cancer (is_implicated_in)

EZH2 LRP1B

8.76e-0472182DOID:10534 (is_implicated_in)
Diseaselung cancer (is_implicated_in)

EZH2 LRP1B

9.25e-0474182DOID:1324 (is_implicated_in)
DiseaseAwakening Epilepsy

HNRNPU ILK

1.13e-0382182C0751111
DiseaseAura

HNRNPU ILK

1.13e-0382182C0236018
DiseaseEpilepsy, Cryptogenic

HNRNPU ILK

1.13e-0382182C0086237
DiseaseEpilepsy

HNRNPU ILK

1.99e-03109182C0014544
Diseasecolorectal cancer (is_implicated_in)

EZH2 LRP1B

2.44e-03121182DOID:9256 (is_implicated_in)
DiseaseMalignant neoplasm of breast

GPC1 EZH2 GOLIM4 MIA2

3.55e-031074184C0006142
Diseaseprostate cancer (is_marker_for)

EZH2 ILK

4.02e-03156182DOID:10283 (is_marker_for)
Diseasecolorectal cancer (is_marker_for)

EZH2 HNRNPU

4.07e-03157182DOID:9256 (is_marker_for)
Diseasehepatocellular carcinoma (is_implicated_in)

EZH2 LRP1B

5.37e-03181182DOID:684 (is_implicated_in)
DiseaseProstatic Neoplasms

EZH2 BAZ2A LRP1B

5.85e-03616183C0033578
DiseaseMalignant neoplasm of prostate

EZH2 BAZ2A LRP1B

5.85e-03616183C0376358

Protein segments in the cluster

PeptideGeneStartEntry
QDDCNGFQDSDDFAD

AFTPH

546

Q6ULP2
DNSFDLNNGSDAEQE

BAZ2A

381

Q9UIF9
DGNQVGANDADSDDE

ASCC2

621

Q9H1I8
SDTDEDNGNGEDFQS

RANBP2

2741

P49792
DNNENAGEDGDNDFS

DCAF1

1441

Q9Y4B6
DGANDCGSNEDESNQ

LRP1B

906

Q9NZR2
NPNQDDDDDEGFSFN

NCBP1

526

Q09161
YNGNDVDFQDASDDG

GPC1

471

P35052
NALGQYNDDDDDDDG

EZH2

176

Q15910
AASEDENGDDQGFQE

HNRNPU

126

Q00839
GDNGEAFFVQETDND

LPIN1

81

Q14693
DAGVEDAADANNGAQ

MARCHF6

241

O60337
YGENDENTDDKNNDG

GOLIM4

641

O00461
DNTENDLNQGDDHGF

ILK

21

Q13418
FDNEDSELNGDYGEN

MIA2

126

Q96PC5
DNQNDDSEEHDDGGY

TRMT13

391

Q9NUP7
EDAFDNNSDIAEDGG

NSD3

31

Q9BZ95
NEDIDDDGHQNNQDN

THBS2

861

P35442
NGNAENEENGEQEAD

PTMA

36

P06454